Total Clarity Wealth Management, Inc.
Position in OVID — Ovid Therapeutics Inc.
CIK 1804909
ST. CHARLES, IL
Position in OVID
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$73,735
+$27,171 QoQ
Shares Held
27,411
+30.7% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#83
of 131 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in OVID Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Total Clarity Wealth Management, Inc. holds $2,767,389 across 7 Biotechnology names. OVID ranks #6 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BBIO |
BridgeBio Pharma, Inc.
|
11,422 | $850,710 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,631 | $810,166 | |
| 3 | CGON |
CG Oncology, Inc.
|
5,719 | $406,334 | |
| 4 | KRYS |
Krystal Biotech, Inc.
|
890 | $330,786 | |
| 5 | ABVX |
Abivax S.A.
|
1,720 | $229,207 | |
| 6 | OVID |
Ovid Therapeutics Inc.
This page
|
27,411 | $73,735 | |
| 7 | PALI |
Palisade Bio, Inc.
|
31,795 | $66,451 |
All Filings in OVID
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $73,735 | 27,411 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $46,564 | 20,975 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $46,618 | 28,600 | Shares | Sole | 2026-02-02 | |
| No filing history on record for this holder in this stock. | ||||||